VANGUARD PORTFOLIO MANAGEMENT LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 2100121
MALVERN, PA
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,460,526
New position
Shares Held
2,665,608
first reported quarter
Ownership
1.54%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VANGUARD PORTFOLIO MANAGEMENT LLC holds $18,331,288 across 2 Drug Manufacturers - Specialty & Generic names. XERS ranks #1 (84.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
2,665,608 | $15,460,526 | |
| 2 | AQST |
Aquestive Therapeutics, Inc.
|
691,750 | $2,870,762 |
All Filings in XERS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,460,526 | 2,665,608 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||